Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST) (PAZOGIST)

This study has been completed.
Information provided by (Responsible Party):
Centre Leon Berard Identifier:
First received: March 10, 2011
Last updated: February 24, 2016
Last verified: February 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2016
  Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)